Actively Recruiting

Phase 3
Age: 18Years - 75Years
All Genders
NCT06455449

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Led by AstraZeneca · Updated on 2026-04-21

240

Participants Needed

234

Research Sites

215 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this multicenter, randomized, placebo-controlled and double-blind study is to evaluate the efficacy and safety of subcutaneous anifrolumab compared with placebo on the overall disease activity in participants with moderate to severe Idiopathic Inflammatory Myopathies (IIM) \[polymyositis (PM) or dermatomyositis (DM)\] while receiving standard of care (SoC) treatment.

CONDITIONS

Official Title

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be between 18 and 75 years old
  • Weigh at least 40 kg
  • Have a "probable" or "definite" diagnosis of polymyositis or dermatomyositis based on 2017 ACR/EULAR criteria
  • Have moderate or severe disease activity
  • Currently be on a stable dose of oral prednisone or other polymyositis or dermatomyositis treatments
  • Have no history of active tuberculosis or severe COVID-19
  • Follow contraception guidelines if male or female
Not Eligible

You will not qualify if you...

  • Diagnosed with inclusion body myositis, immune-mediated necrotizing myositis, juvenile myositis diagnosed within 10 years, drug-induced myositis, cancer-associated myositis, amyopathic dermatomyositis, or non-inflammatory myopathies like muscular dystrophies
  • At high risk of malignancy
  • Have rapidly progressive interstitial lung disease
  • Have severe muscle damage or permanent weakness due to conditions other than polymyositis or dermatomyositis
  • History of severe herpes zoster infection
  • History of cancer (except treated basal cell carcinoma or cervical cancer in situ), immunodeficiency, HIV, HBV, or active HCV
  • Ongoing cytomegalovirus or Epstein-Barr virus infection within 12 weeks prior to consent
  • Opportunistic infection requiring hospitalization or IV antimicrobial treatment within 3 years prior to randomization
  • Recent non-opportunistic infection requiring hospitalization or anti-infective treatment
  • Recent or current participation in another clinical study with an investigational product
  • Lactating, breastfeeding, pregnant, or planning to become pregnant or breastfeed

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 234 locations

1

Research Site

Phoenix, Arizona, United States, 85032

Not Yet Recruiting

2

Research Site

Irvine, California, United States, 92617

Actively Recruiting

3

Research Site

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Research Site

Denver, Colorado, United States, 80230

Not Yet Recruiting

5

Research Site

New Haven, Connecticut, United States, 06519

Actively Recruiting

6

Research Site

Washington D.C., District of Columbia, United States, 20037

Withdrawn

7

Research Site

Boca Raton, Florida, United States, 33486

Actively Recruiting

8

Research Site

Boynton Beach, Florida, United States, 33472

Withdrawn

9

Research Site

Gainesville, Florida, United States, 32603

Withdrawn

10

Research Site

Margate, Florida, United States, 33063

Actively Recruiting

11

Research Site

Miami, Florida, United States, 33126

Withdrawn

12

Research Site

Miami, Florida, United States, 33133

Actively Recruiting

13

Research Site

Orlando, Florida, United States, 32819

Actively Recruiting

14

Research Site

Palm Beach Gardens, Florida, United States, 33410

Actively Recruiting

15

Research Site

Plant City, Florida, United States, 33563

Actively Recruiting

16

Research Site

Atlanta, Georgia, United States, 30322

Actively Recruiting

17

Research Site

Willowbrook, Illinois, United States, 60527

Actively Recruiting

18

Research Site

Fairway, Kansas, United States, 66205

Actively Recruiting

19

Research Site

Baltimore, Maryland, United States, 21224

Actively Recruiting

20

Research Site

Boston, Massachusetts, United States, 02115

Not Yet Recruiting

21

Research Site

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

22

Research Site

Sterling Heights, Michigan, United States, 48313

Not Yet Recruiting

23

Research Site

Great Neck, New York, United States, 11021

Not Yet Recruiting

24

Research Site

Charlotte, North Carolina, United States, 28207

Withdrawn

25

Research Site

Charlotte, North Carolina, United States, 28211

Actively Recruiting

26

Research Site

Durham, North Carolina, United States, 27710

Actively Recruiting

27

Research Site

Cleveland, Ohio, United States, 44195

Actively Recruiting

28

Research Site

Middleburg Heights, Ohio, United States, 44130

Withdrawn

29

Research Site

Philadelphia, Pennsylvania, United States, 19107

Not Yet Recruiting

30

Research Site

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

31

Research Site

Charleston, South Carolina, United States, 29425

Actively Recruiting

32

Research Site

Summerville, South Carolina, United States, 29486

Actively Recruiting

33

Research Site

Allen, Texas, United States, 75013

Actively Recruiting

34

Research Site

Austin, Texas, United States, 78759

Not Yet Recruiting

35

Research Site

Colleyville, Texas, United States, 76034

Actively Recruiting

36

Research Site

El Paso, Texas, United States, 79902

Actively Recruiting

37

Research Site

Galveston, Texas, United States, 77555

Withdrawn

38

Research Site

Harlingen, Texas, United States, 78550

Not Yet Recruiting

39

Research Site

Houston, Texas, United States, 77030

Withdrawn

40

Research Site

North Richland Hills, Texas, United States, 76180

Actively Recruiting

41

Research Site

Beckley, West Virginia, United States, 25801

Not Yet Recruiting

42

Research Site

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

43

Research Site

Buenos Aires, Argentina, C1180AAX

Actively Recruiting

44

Research Site

CABA, Argentina, C1431FWO

Actively Recruiting

45

Research Site

Ciudad de Buenos Aires, Argentina, C1405BCH

Actively Recruiting

46

Research Site

Quilmes, Argentina, B1878GEG

Actively Recruiting

47

Research Site

San Miguel de Tucumán, Argentina, T4000AXL

Actively Recruiting

48

Research Site

Camperdown, Australia, 2050

Actively Recruiting

49

Research Site

Nedlands, Australia, 6009

Actively Recruiting

50

Research Site

New Lambton, Australia, 2310

Withdrawn

51

Research Site

Southport, Australia, 4222

Actively Recruiting

52

Research Site

Woodville South, Australia, 5011

Actively Recruiting

53

Research Site

Graz, Austria, 8036

Actively Recruiting

54

Research Site

Vienna, Austria, 1090

Actively Recruiting

55

Research Site

Ghent, Belgium, 9000

Actively Recruiting

56

Research Site

Leuven, Belgium, 3000

Actively Recruiting

57

Research Site

Merksem, Belgium, B-2170

Withdrawn

58

Research Site

Joinville, Brazil, 89202-190

Actively Recruiting

59

Research Site

Juiz de Fora, Brazil, 36010 570

Actively Recruiting

60

Research Site

Pelotas, Brazil, 96040-010

Withdrawn

61

Research Site

Porto Alegre, Brazil, 90620-110

Actively Recruiting

62

Research Site

Salvador, Brazil, 40150-150

Actively Recruiting

63

Research Site

Salvador, Brazil, 41253-190

Actively Recruiting

64

Research Site

São José do Rio Preto, Brazil, 15090-000

Actively Recruiting

65

Research Site

São Paulo, Brazil, 01233-907

Actively Recruiting

66

Research Site

São Paulo, Brazil, 5403-000

Not Yet Recruiting

67

Research Site

Haskovo, Bulgaria, 6304

Actively Recruiting

68

Research Site

Plovdiv, Bulgaria, 4001

Actively Recruiting

69

Research Site

Plovdiv, Bulgaria, 4002

Withdrawn

70

Research Site

Plovdiv, Bulgaria, 4002

Actively Recruiting

71

Research Site

Rousse, Bulgaria, 7000

Not Yet Recruiting

72

Research Site

Sofia, Bulgaria, 1680

Actively Recruiting

73

Research Site

Stara Zagora, Bulgaria, 6003

Withdrawn

74

Research Site

Calgary, Alberta, Canada, T2N 4L7

Actively Recruiting

75

Research Site

Calgary, Alberta, Canada, T3M1M4

Withdrawn

76

Research Site

Montreal, Quebec, Canada, H3T 1E2

Actively Recruiting

77

Research Site

Concepción, Chile, 4070022

Actively Recruiting

78

Research Site

Las Condes, Chile, 7560908

Actively Recruiting

79

Research Site

Osorno, Chile, 200025

Actively Recruiting

80

Research Site

Santiago, Chile, 7691236

Withdrawn

81

Research Site

Santiago, Chile, 8330034

Actively Recruiting

82

Research Site

Santiago, Chile, 8420383

Withdrawn

83

Research Site

Beijing, China, 100029

Actively Recruiting

84

Research Site

Beijing, China, 100044

Withdrawn

85

Research Site

Beijing, China, 100191

Actively Recruiting

86

Research Site

Beijing, China, CN-100730

Actively Recruiting

87

Research Site

Chongqing, China, 402260

Actively Recruiting

88

Research Site

Dongguan, China, 523009

Actively Recruiting

89

Research Site

Guangzhou, China, 510317

Actively Recruiting

90

Research Site

Guangzhou, China, 510630

Actively Recruiting

91

Research Site

Hangzhou, China, 310014

Actively Recruiting

92

Research Site

Hengyang, China, 421001

Actively Recruiting

93

Research Site

Jining, China, 272011

Actively Recruiting

94

Research Site

Nanjing, China, 210029

Actively Recruiting

95

Research Site

Shanghai, China, 200025

Actively Recruiting

96

Research Site

Shanghai, China, 200032

Actively Recruiting

97

Research Site

Shanghai, China, 200040

Actively Recruiting

98

Research Site

Shanghai, China

Actively Recruiting

99

Research Site

Shijiazhuang, China, 050001

Actively Recruiting

100

Research Site

Wenzhou, China, 325000

Actively Recruiting

101

Research Site

Zhengzhou, China, 450052

Actively Recruiting

102

Research Site

Prague, Czechia, 12850

Actively Recruiting

103

Research Site

Aarhus N, Denmark, 8200

Actively Recruiting

104

Research Site

Copenhagen, Denmark, 2100

Withdrawn

105

Research Site

Odense C, Denmark, 5000

Actively Recruiting

106

Research Site

Angers, France, 49033

Actively Recruiting

107

Research Site

Brest, France, 29609

Actively Recruiting

108

Research Site

Le Mans, France, 72037

Actively Recruiting

109

Research Site

Lille, France, 59037

Actively Recruiting

110

Research Site

Lyon, France, 69437

Actively Recruiting

111

Research Site

Paris, France, 75010

Actively Recruiting

112

Research Site

Paris, France, 75651

Actively Recruiting

113

Research Site

Reims, France, 51100

Actively Recruiting

114

Research Site

Rouen, France, 76000

Actively Recruiting

115

Research Site

Strasbourg, France, 67098

Actively Recruiting

116

Research Site

Toulouse, France, 31059

Actively Recruiting

117

Research Site

Bad Nauheim, Germany, 61231

Withdrawn

118

Research Site

Berlin, Germany, 10117

Actively Recruiting

119

Research Site

Bonn, Germany, 53127

Actively Recruiting

120

Research Site

Freiburg im Breisgau, Germany, 79106

Actively Recruiting

121

Research Site

Herne, Germany, 44649

Not Yet Recruiting

122

Research Site

München, Germany, 80336

Actively Recruiting

123

Research Site

Tübingen, Germany, 72076

Actively Recruiting

124

Research Site

Budapest, Hungary, 1023

Not Yet Recruiting

125

Research Site

Debrecen, Hungary, 4032

Actively Recruiting

126

Research Site

Szeged, Hungary, 6725

Actively Recruiting

127

Research Site

Ahmedabad, India, 380006

Withdrawn

128

Research Site

Ahmedabad, India, 382421

Withdrawn

129

Research Site

Dehradun, India, 248016

Withdrawn

130

Research Site

Delhi, India, 110029

Not Yet Recruiting

131

Research Site

Gurugram, India, 122001

Withdrawn

132

Research Site

Hyderabad, India, 500082

Actively Recruiting

133

Research Site

Kolkata, India, 700020

Actively Recruiting

134

Research Site

Lucknow, India, 226030

Actively Recruiting

135

Research Site

Mumbai, India, 400 078

Withdrawn

136

Research Site

Mumbai, India, 400012

Withdrawn

137

Research Site

Mumbai, India, 400053

Actively Recruiting

138

Research Site

Mysuru, India, 570004

Actively Recruiting

139

Research Site

New Delhi, India, 110060

Withdrawn

140

Research Site

Puducherry, India, 605006

Withdrawn

141

Research Site

Secunderabad, India, 500003

Actively Recruiting

142

Research Site

Afula, Israel, 18101

Actively Recruiting

143

Research Site

Haifa, Israel, 31048

Actively Recruiting

144

Research Site

Haifa, Israel, 34362

Actively Recruiting

145

Research Site

Jerusalem, Israel, 91120

Actively Recruiting

146

Research Site

Kfar Saba, Israel, 4428164

Actively Recruiting

147

Research Site

Ramat Gan, Israel, 52621

Actively Recruiting

148

Research Site

Ancona, Italy, 60126

Actively Recruiting

149

Research Site

Bari, Italy, 70124

Actively Recruiting

150

Research Site

Catania, Italy, 95100

Actively Recruiting

151

Research Site

Milan, Italy, 20132

Actively Recruiting

152

Research Site

Milan, Italy, 20161

Withdrawn

153

Research Site

Padova, Italy, 35128

Actively Recruiting

154

Research Site

Palermo, Italy, 90127

Withdrawn

155

Research Site

Pavia, Italy, 27100

Actively Recruiting

156

Research Site

Pisa, Italy, 56126

Withdrawn

157

Research Site

Roma, Italy, 00128

Withdrawn

158

Research Site

Roma, Italy, 00161

Withdrawn

159

Research Site

Roma, Italy, 00189

Actively Recruiting

160

Research Site

Rozzano, Italy, 20089

Actively Recruiting

161

Research Site

Siena, Italy, 53100

Suspended

162

Research Site

Asahikawa-Shi, Japan, 070-8644

Actively Recruiting

163

Research Site

Bunkyō City, Japan, 113-8431

Not Yet Recruiting

164

Research Site

Bunkyō City, Japan, 113-8603

Actively Recruiting

165

Research Site

Chiba, Japan, 260-0877

Withdrawn

166

Research Site

Fukuoka, Japan, 810-8563

Actively Recruiting

167

Research Site

Hiroshima, Japan, 734-8551

Not Yet Recruiting

168

Research Site

Iruma-Gun, Japan, 350-0495

Actively Recruiting

169

Research Site

Kawachinagano-shi, Japan, 586-8521

Actively Recruiting

170

Research Site

Kawasaki-shi, Japan, 216-8511

Actively Recruiting

171

Research Site

Nagoya, Japan, 457-0866

Actively Recruiting

172

Research Site

Nagoya, Japan, 467-0001

Actively Recruiting

173

Research Site

Okayama, Japan, 700-8557

Actively Recruiting

174

Research Site

Omura-shi, Japan, 856-8562

Actively Recruiting

175

Research Site

Sendai, Japan, 980-8574

Actively Recruiting

176

Research Site

Shinjuku-ku, Japan, 160-8582

Actively Recruiting

177

Research Site

Tachikawa-shi, Japan, 190-0014

Actively Recruiting

178

Research Site

Yotsukaido-shi, Japan, 284-0003

Actively Recruiting

179

Research Site

Culiacán, Mexico, 80020

Actively Recruiting

180

Research Site

D.F, Mexico, 14000

Withdrawn

181

Research Site

Guadalajara, Mexico, 44600

Actively Recruiting

182

Research Site

Guadalajara, Mexico, 44650

Not Yet Recruiting

183

Research Site

Guadalajara, Mexico, 44690

Actively Recruiting

184

Research Site

Mexico City, Mexico, 03310

Actively Recruiting

185

Research Site

Mexico City, Mexico, 06700

Actively Recruiting

186

Research Site

México, Mexico, 06090

Withdrawn

187

Research Site

México, Mexico, 11850

Actively Recruiting

188

Research Site

Amsterdam, Netherlands, 1105 AZ

Actively Recruiting

189

Research Site

Bialystok, Poland, 15-276

Withdrawn

190

Research Site

Krakow, Poland, 30-002

Actively Recruiting

191

Research Site

Krakow, Poland, 30-721

Actively Recruiting

192

Research Site

Lodz, Poland, 90-549

Actively Recruiting

193

Research Site

Poznan, Poland, 60-218

Actively Recruiting

194

Research Site

Poznan, Poland, 61-545

Actively Recruiting

195

Research Site

Warsaw, Poland, 00-874

Actively Recruiting

196

Research Site

Warsaw, Poland, 02-637

Actively Recruiting

197

Research Site

Wroclaw, Poland, 50-556

Actively Recruiting

198

Research Site

Caguas, Puerto Rico, 00725

Actively Recruiting

199

Research Site

San Juan, Puerto Rico, 00918

Actively Recruiting

200

Research Site

Daejeon, South Korea, 35015

Actively Recruiting

201

Research Site

Seoul, South Korea, 02447

Actively Recruiting

202

Research Site

Seoul, South Korea, 04401

Actively Recruiting

203

Research Site

Seoul, South Korea, 06591

Actively Recruiting

204

Research Site

Seoul, South Korea, 133792

Actively Recruiting

205

Research Site

A Coruña, Spain, 15006

Active, Not Recruiting

206

Research Site

Barcelona, Spain, 08003

Actively Recruiting

207

Research Site

Barcelona, Spain, 08035

Actively Recruiting

208

Research Site

Barcelona, Spain, 08041

Actively Recruiting

209

Research Site

Córdoba, Spain, 14004

Actively Recruiting

210

Research Site

L'Hospitalet de Llobregat, Spain, 08907

Actively Recruiting

211

Research Site

Madrid, Spain, 28034

Actively Recruiting

212

Research Site

Madrid, Spain, 28041

Actively Recruiting

213

Research Site

Sabadell, Spain, 08208

Actively Recruiting

214

Research Site

Valladolid, Spain, 47012

Actively Recruiting

215

Research Site

Stockholm, Sweden, 171 76

Withdrawn

216

Research Site

Uppsala, Sweden, 751 85

Actively Recruiting

217

Research Site

Kaohsiung City, Taiwan, 81362

Actively Recruiting

218

Research Site

Kaohsiung City, Taiwan, 833

Actively Recruiting

219

Research Site

New Taipei City, Taiwan, 220

Actively Recruiting

220

Research Site

Taichung, Taiwan, 40447

Terminated

221

Research Site

Taichung, Taiwan, 40705

Actively Recruiting

222

Research Site

Taipei, Taiwan, 112

Withdrawn

223

Research Site

Taoyuan, Taiwan, 333

Withdrawn

224

Research Site

Edinburgh, United Kingdom, EH4 2XU

Actively Recruiting

225

Research Site

London, United Kingdom, NW3 2QG

Actively Recruiting

226

Research Site

Wolverhampton, United Kingdom, WV10 0QP

Actively Recruiting

227

Research Site

Hanoi, Vietnam, 100000

Actively Recruiting

228

Research Site

Hanoi, Vietnam, 10000

Withdrawn

229

Research Site

Hà Nội, Vietnam, 100000

Actively Recruiting

230

Research Site

Hà Nội, Vietnam, 100000

Withdrawn

231

Research Site

Ho Chi Minh City, Vietnam, 700000

Actively Recruiting

232

Research Site

Hochiminh City, Vietnam, 700000

Withdrawn

233

Research Site

Hồ Chí Minh, Vietnam, 700000

Actively Recruiting

234

Research Site

Huế, Vietnam, 530000

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) | DecenTrialz